Investor Relations

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them.

CR-000172

Investor Overview

Investor Overview

Corporate Profile

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

News Releases

Date Title and Summary Additional Formats
Toggle Summary Charles River Laboratories Announces Updates to Microbial Solutions Product Portfolio
New EndoScan-V™ endotoxin detection software and Celsis ® automated detection platform for rapid sterility introduced to address unmet industry needs WILMINGTON, Mass. --(BUSINESS WIRE)--Sep. 9, 2019-- Charles River Laboratories International, Inc. (NYSE: CRL) today announced the launch of two new
View HTML
Toggle Summary Charles River Laboratories to Host 3rd Annual World Congress
The two-day event will highlight strategies for delivering drugs to patients faster WILMINGTON, Mass. --(BUSINESS WIRE)--Sep. 5, 2019-- Charles River Laboratories International, Inc. is proud to host the 3 rd Annual World Congress : Delivering Therapies to the Clinic Faster on September 23-24, 2019
View HTML
Toggle Summary Charles River Laboratories to Present at Baird and Morgan Stanley Investor Conferences
- Company to Host an Investor Day on September 12 th - WILMINGTON, Mass. --(BUSINESS WIRE)--Sep. 3, 2019-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Baird 2019 Global Healthcare Conference in New York on Thursday, September 5 th , at
View HTML
Toggle Summary Charles River Laboratories Announces Second-Quarter 2019 Results
– Second-Quarter Revenue of $657.6 Million – – Second-Quarter GAAP Earnings per Share of $0.88 and Non-GAAP Earnings per Share of $1.63 – – Updates 2019 Guidance – WILMINGTON, Mass. --(BUSINESS WIRE)--Jul. 31, 2019-- Charles River Laboratories International, Inc.
View HTML
Upcoming Events
There are currently no events scheduled.

Featured Report

2018 Annual Report (PDF)

Investor Hotline

877-567-6CRL (6275)